Development and characterization of novel pharmaceutical crystalline complex of Lomefloxacin

International Journal of Drug Development and Research

Volumn 4, Issue 1, 2012, Pages 227-233

  Nanjwade, Veerendra K ^a   Manvi, F V ^a   Shamrez Ali, M ^b   Maste, Meenaxi M ^a   Nanjwade, Basavaraj K ^a  

^a K L E S S COLLEGE OF PHARMACY   (India)

^b Simpex Pharma Pvt Ltd   (India)

Author keywords

Cocrystals; Dissolution rates; Lomefloxacin; Product development

Indexed keywords

LOMEFLOXACIN; SALICYLIC ACID; UREA;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG PURITY; DRUG SOLUBILITY; DRUG STABILITY; INFRARED SPECTROSCOPY; MELTING POINT; MOLECULAR INTERACTION; PHYSICAL CHEMISTRY; X RAY POWDER DIFFRACTION;

EID: 84861303154     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst. Growth Des 2009; 9(6): 2950-2967.
2. Jung MS et al. Bioavailability of indomethacin-saccharin cocrystals. J Pharm Pharmacol2010; 62(11): 1560-1568.
3. Vishweshwar P et al. Pharmaceutical cocrystals. J Pharm Sci 2006; 95(3): 499-516.
4. Trask AV, Jones W. Crystal engineering of organic cocrystals by the solid-state grinding approach. Top CurrChem 2005; 41-70.
5. Berry D, Seaton C, Clegg W, Harrington R, Coles S, Horton P, Hursthouse M, Storey R, Jones W, Friscic T. Cryst. Growth Des. 2008; (8), 1697-1712.
6. Basavoju S et al. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm Res 2008; 25(3): 530-541.
7. BrittainH. Polymorphism in Pharmaceutical Solids. New York: Marcel Dekker, Inc., 1999.
8. ThayerAM. Form and function. ChemEng News2007; 85(25): 17-30.
9. Vishweshwar P et al. Pharmaceutical cocrystals. J Pharm Sci2006; (95): 499-516.
10. Jones W et al. Pharmaceutical cocrystals: an emerging approachto physical property enhancement. MRS Bull2006; 31: 875-879.
11. Schultheiss N, Newman A. Pharmaceutical cocrystals and theirphysicochemical properties. Cryst Growth Des2009; 9(6): 2950-2967.
12. Trask AV, Jones W. Achievingpolymorphic and stoichiometric diversity in cocrysatal formation: importance of solid state grinding, powder x-ray structure determination seeding, Cryst. Growth Des. 9(20009) 1106-1123.
13. Vishweshwar P et al. Synthesis and structural characterization of cocrystal and pharmaceutical cocrystals: mechanochemitstry vs. slow evaporation from solutionCryst. Growth Des. 9(2009) 1106-1123.